Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

26.67
Delayed Data
As of 10:17am ET
 -0.87 / -3.16%
Today’s Change
16.75
Today|||52-Week Range
51.89
-19.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues57.4M11.6M14.4M48.4M
 
 
 
 
 
Depreciation And Amortization141.0K165.0K204.0K339.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses8.7M9.7M10.5M12.5M
 
 
 
 
 
Research And Development5.4M6.3M7.0M9.0M
 
 
 
 
 
Total Operating Expenses8.8M9.9M10.7M12.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income48.6M1.7M3.7M35.6M
 
 
 
 
 
Extraordinary Credit0.00--203.0K0.00
 
 
Extraordinary Charge-17.0K-15.0K0.00-15.0K
 
 
 
 
Interest Expense On Debt2.0K2.0K2.0K12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income48.8M2.0M4.2M35.9M
 
 
 
 
 
Income Taxes-20.0M-428.0K-1.6M-9.7M
 
 
 
 
 
Net Income28.8M2.4M5.8M26.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.7M18.7M18.7M18.8M
 
 
 
 
 
Shares To Calculate EPS Diluted19.3M19.3M19.3M19.3M
 
 
 
 
 
 
Earnings Per ShareEPS$1.49$0.13$0.29$1.36
 
 
 
 
 
EPS Diluted$1.49$0.13$0.29$1.36